AN2 Therapeutics, Inc.
- Last sale
- Nov 6, 2026 · +0.50%
- Market cap
- $151.40M
- 37.94M shares
- Filings
- 390
—
—
—Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
—
—
—Q3 2026N/M FY25 yoy
Q3 2026−6.6% FY25 yoy
- $151.40M
- —
- —
- 2.0×
- —
- —
FY2025 figures · derived
Price
Nov 6, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $24,769,000 | reported | |
| FY 2024 | 2024-12-31 | $40,488,000 | reported | |
| FY 2023 | 2023-12-31 | $54,871,000 | reported | |
| FY 2022 | 2022-12-31 | $28,511,000 | reported | |
| FY 2021 | 2021-12-31 | $16,156,000 | reported |
Pharmaceutical preparations
AN2 Therapeutics, Inc. is the 265th largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
VICPVicapsys Life Sciences, Inc.Fiscal 2023 figures———$160.4MUPBUpstream Bio, Inc.$2.9M20.4%5,026.0%$156.5MSLGLSol-Gel Technologies Ltd.$19.4M68.0%31.6%$156.0MSIONSionna Therapeutics, Inc.———$154.9M
ANTXAN2 Therapeutics, Inc. (this company)———$151.4M
MGNXMacrogenics Inc$149.5M0.3%49.9%$146.7MPRQRProQR Therapeutics N.V.———$142.2MNTHINeonc Technologies Holdings, Inc.$40.0K51.8%155,404.4%$139.8MAKBAAkebia Therapeutics, Inc.$236.2M47.5%2.3%$138.5MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
AN2 Therapeutics, Inc. · CIK 1880438 · Engraved from SEC EDGAR